BPS-001 Mechanism of Action

The best strategy for attacking prostate cancer is with an agent that targets multiple pathways involved in carcinogenesis. BPS-001, unlike the available single agent therapies for treating prostate cancer, is a multivalent, complex biologic drug candidate containing a known and consistent composition of active, anticancer components. Preliminary data on the mechanisms of action behind BPS-001 have shown that BPS-001 demonstrates anti-tumour activities attributable, at least partly to inhibiting angiogenesis and cell cycle progression, altering cell adhesion properties and increasing apoptosis.